Leading the Way in Life Science Technologies

GEN Exclusives

More »

October 1, Vol. 27, No. 17

  • Feature Articles

    • Personalized Medicine Seeks Mainstream
    • Elizabeth Lipp
    • Harvard Medical School is hosting “Personalized Medicine: A Call to Action” at the end of November Participants will discuss obstacles to the adoption of personalized medicine and showcase evidence that will stimulate stakeholders to act and overcome these barriers All ... more »
    • CMOs Focused on Meeting Needs and Time Lines
    • William Downey
    • Investments in new technologies, service offerings, and capacity are just a sample of activities undertaken by contract manufacturing organizations (CMOs) to meet the ever-increasing demands from pharmaceutical and biotechnology industry clients In HighTech Business Decisions’ recent report, Biopharmaceutical Contract Manufacturing ... more »
    • Producing Biologics Less Expensively
    • Sue Pearson
    • Protein-based drugs are luxury goods, according to François Arcand, CEO, ERA Biotech (wwwerabiotechcom) “Since most have the same market size as Cartier watches, I believe no health system in the world has the financial means to supply its general population ... more »
    • Benefits Point Biotech Firms to Buffalo
    • Vicki Brower
    • Buffalo is sprouting a number of biotech companies to commercialize capabilities in life science research and expertise in oncology, neurology, pharmacology, and bioinformatics The Buffalo Niagara region has been a center of medical device and biotech tool innovation for some ... more »
  • Columns

    • Risk-Averse Behavior Entrenched at FDA
    • Henry I. Miller, M.D.
    • The 2006 survey of biopharmaceutical companies’ views of FDA oversight released last month yielded puzzling and worrisome results The study, by a biotechnology industry group and a major consulting firm, generally has been spun as portraying the regulatory environment as ... more »
    • Alpha Biologics Takes Global Approach
    • Sophia Fox
    • Contract biologics manufacturer Alpha Biologics (wwwalphabiologicscom) capitalizes on the benefits of a dual operation—European headquarters and process development facilities and Malaysian manufacturing sites The company says that this translates into more cost-effective manufacturing for clients while retaining the scientific, process ... more »